NCT07285434
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
- Locations
-
- Biogenea Pharmaceuticals Ltd Thessaloniki, Macedonia, Greece
Clinical trial condition
Carcinoma, Non-Small-Cell Lung
Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.
4,689 public trials
1,036 recruiting studies
Carcinoma, Non-Small-Cell Lung trial results
Enrolling by Invitation
Using CICS-1 and SPM-011 and ［18F］FBPA Commissioned by CICS and Sumitomo Heavy Industries and STELLA PHARMA
NCT06603987
- Conditions
- Adenoma, Breast Diseases, Breast Neoplasms, +40 more
- Locations
-
- ORIX Kouraibashi Bldg. 8F 3-2-7 Kouraibashi Chuo-ku Osaka, Japan
Enrolling by Invitation
Evaluating the Feasibility and Preliminary Effects of BE+
NCT07214441
- Conditions
- Behavior, Bronchial Neoplasms, Carcinoma, Bronchogenic, +15 more
- Locations
-
- University of South Carolina Columbia, South Carolina, United States
Enrolling by Invitation
Liquid BiOpsy, Lung and Colon Cancer in AndaluciA
NCT06997458
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +22 more
- Locations
-
- Centre for Genomics and Oncological Research - Pfizer - University of Granada - Andalusian Regional Government (GENyO) Granada, Andalusia, Spain
Enrolling by Invitation
Real-World Assessment of Therapeutic Strategies and Survival Outcomes Following First-Line Tislelizumab Therapy in Advanced Non-Small Cell Lung Cancer
NCT06962449
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
- Locations
-
- Shanghai Chest Hospital Shanghai, Shanghai Municipality, China
Enrolling by Invitation
Evaluation of [18F]AlF-NOTA-PCP2 PET/CT for PD-L1 Detection in Malignant Tumors
NCT06690216
- Conditions
- Astrocytoma, Bronchial Neoplasms, Carcinoma, +30 more
- Locations
-
- Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences Jinan, Shandong, China
Enrolling by Invitation
Efficacy and Safety of Sintilimab Combined with Platinum-containing Double-agent Chemotherapy in First-line Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer in Elderly Patients
NCT06883136
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Degan Lu Jinan, Shandong, China
- The First Affiliated Hospital of Shandong First Medical University Jinan, Shandong, China
Enrolling by Invitation
LORLATINIB-related HYPERLIPIDEMIA in ALK+ Non-Small Cell Lung Cancer
NCT06876675
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +14 more
- Locations
-
- Peking University Third Hospital Beijing, China
Enrolling by Invitation
FHND9041 Versus Afatinib for Non-small Cell Lung Cancer
NCT06759857
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Cancer Hospital Chinese Academy of Medical Sciences Beijing, China
Enrolling by Invitation
Cryobiopsy Vs. Forceps Biopsy for Peripheral Pulmonary Lesions
NCT06752395
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Pusan National University Hospital Busan, South Korea
- Yeungnam University Medical Center Daegu, South Korea
- Chungnam National University Hospital Daejeon, South Korea